Effect of the 5-hydroxytryptamine(3) (5-HT3)-receptor antagonist KB-R6933 on experimental diarrhea models

Citation
A. Ozaki et al., Effect of the 5-hydroxytryptamine(3) (5-HT3)-receptor antagonist KB-R6933 on experimental diarrhea models, JPN J PHARM, 80(1), 1999, pp. 93-96
Citations number
15
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JAPANESE JOURNAL OF PHARMACOLOGY
ISSN journal
00215198 → ACNP
Volume
80
Issue
1
Year of publication
1999
Pages
93 - 96
Database
ISI
SICI code
0021-5198(199905)80:1<93:EOT5(A>2.0.ZU;2-L
Abstract
The effects of a 5-hydroxytryptamine(3) (5-HT3)-receptor antagonist KB-R693 3 (6-amino-5-chloro-1-isopropyl-2-(4-methyl-1-piperazinyl)-benzimidazole di maleate) on experimental diarrhea and on intestinal fluid secretion stimula ted by cholera toxin were examined and compared with those of ramosetron an d loperamide. KB-R6933 and ramosetron (0.03 -1 mg/kg, p.o.) inhibited the d iarrhea induced by 5-HT, but not that by castor oil or prostaglandin E-2 (P GE(2)), in mice. Loperamide significantly inhibited the diarrhea induced by 5-HT, castor oil and PGE(2). All drugs tested inhibited the diarrhea induc ed by restraint stress and the intestinal fluid secretion stimulated by cho lera toxin in rats. The results suggest the possibility that KB-R6933 may h ave clinical efficacy in the treatment of diarrhea.